-
摘要: 尽管超声心动图主要用作大多数心血管患者的一线影像学检查手段,随着心脏磁共振成像(cardiac magnetic resonance,CMR)技术的发展,其不仅能够提供心脏、大血管及周围组织的结构与测量相关功能参数,而且其多角度多序列成像可分辨组织学特征,能够实现病理无创化影像化,在疾病的诊断、预后和危险分层中均发挥重要指导价值。本文将简要阐述CMR及其相关技术在心力衰竭中的应用现状。Abstract: With the advancement of cardiac magnetic resonance(CMR), it has shown unique values in characterizing the myocardium, the great vessels, and surrounding tissues in assessing heart failure(HF). The multi-sequence, multi-modulation, and non-invasive imaging can distinguish histological features and functional parameters related to structure and measurement. CMR plays an important guiding value in the diagnosis, prognosis, and risk stratification of HFs. This review article briefly describes the application of related technologies of CMR in HF.
-
Key words:
- cardiac magnetic resonance /
- heart failure /
- late gadolinium enhancement /
- mapping
-
[1] 中国心血管健康与疾病报告编写组, 胡盛寿. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志, 2021, 36(6): 521-545. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXH202106001.htm
[2] Wang H, Chai K, Du M, et al. Prevalence and Incidence of Heart Failure Among Urban Patients in China: A National Population-Based Analysis[J]. Circ Heart Fail, 2021, 14(10): e008406. doi: 10.1161/CIRCHEARTFAILURE.121.008406
[3] Rozanski A, Muhlestein JB, Berman DS. Primary Prevention of CVD: The Role of Imaging Trials[J]. JACC Cardiovasc Imaging, 2017, 10(3): 304-317. doi: 10.1016/j.jcmg.2017.01.009
[4] Seetharam K, Lerakis S. Cardiac magnetic resonance imaging: the future is bright[J]. F1000Res, 2019, 8.
[5] Malik SB, Chen N, Parker RA 3rd, et al. Transthoracic Echocardiography: Pitfalls and Limitations as Delineated at Cardiac CT and MR Imaging-Erratum[J]. Radiographics, 2017, 37(3): 1004.
[6] Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance(CMR): Consensus Panel report[J]. J Cardiovasc Magn Reson, 2004, 6(4): 727-765. doi: 10.1081/JCMR-200038581
[7] Leiner T, Bogaert J, Friedrich MG, et al. SCMR Position Paper(2020) on clinical indications for cardiovascular magnetic resonance[J]. J Cardiovasc Magn Reson, 2020, 22(1): 76. doi: 10.1186/s12968-020-00682-4
[8] Busse A, Rajagopal R, Yücel S, et al. Cardiac MRI-Update 2020[J]. Radiologe, 2020, 60(Suppl 1): 33-40.
[9] Russo V, Lovato L, Ligabue G. Cardiac MRI: technical basis[J]. Radiol Med, 2020, 125(11): 1040-1055. doi: 10.1007/s11547-020-01282-z
[10] Granitz M, Motloch LJ, Granitz C, et al. Comparison of native myocardial T1 and T2 mapping at 1.5T and 3T in healthy volunteers: Reference values and clinical implications[J]. Wien Klin Wochenschr, 2019, 131(7-8): 143-155. doi: 10.1007/s00508-018-1411-3
[11] Newman K, Wilson R, Roberts JM, et al. Tricuspid annular plane systolic excursion for the evaluation of right ventricular function in functional cardiac CT compared to MRI[J]. Clin Radiol, 2021, 76(8): 628. e1-628. e7. doi: 10.1016/j.crad.2021.02.018
[12] Messroghli DR, Moon JC, Ferreira VM, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance(SCMR)endorsed by the European Association for Cardiovascular Imaging(EACVI)[J]. J Cardiovasc Magn Reson, 2017, 19(1): 75. doi: 10.1186/s12968-017-0389-8
[13] Ho N, Nesbitt G, Hanneman K, et al. Assessment of Pericardial Disease with Cardiovascular MRI[J]. Heart Fail Clin, 2021, 17(1): 109-120. doi: 10.1016/j.hfc.2020.08.008
[14] Cau R, Bassareo P, Suri JS, et al. The emerging role of atrial strain assessed by cardiac MRI in different cardiovascular settings: an up-to-date review[J]. Eur Radiol, 2022, 32(7): 4384-4394. doi: 10.1007/s00330-022-08598-6
[15] Amzulescu MS, De Craene M, Langet H, et al. Myocardial strain imaging: review of general principles, validation, and sources of discrepancies[J]. Eur Heart J Cardiovasc Imaging, 2019, 20(6): 605-619. doi: 10.1093/ehjci/jez041
[16] Di Marco A, Anguera I, Schmitt M, et al. Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis[J]. JACC Heart Fail, 2017, 5(1): 28-38. doi: 10.1016/j.jchf.2016.09.017
[17] Pirruccello JP, Bick A, Wang M, et al. Analysis of cardiac magnetic resonance imaging in 36, 000 individuals yields genetic insights into dilated cardiomyopathy[J]. Nat Commun, 2020, 11(1): 2254. doi: 10.1038/s41467-020-15823-7
[18] Almeida PC, Lopes V, Ferreira LA, et al. Role of Cardiac Magnetic Resonance in the Diagnosis of Infiltrative, Hypertrophic, and Arrhythmogenic Cardiomyopathies[J]. Front Biosci(Schol Ed), 2022, 14(1): 7.
[19] Weng Z, Yao J, Chan RH, et al. Prognostic Value of LGE-CMR in HCM: A Meta-Analysis[J]. JACC Cardiovasc Imaging, 2016, 9(12): 1392-1402. doi: 10.1016/j.jcmg.2016.02.031
[20] Geske JB, Ommen SR, Gersh BJ. Hypertrophic Cardiomyopathy: Clinical Update[J]. JACC Heart Fail, 2018, 6(5): 364-375. doi: 10.1016/j.jchf.2018.02.010
[21] Captur G, Manisty CH, Raman B, et al. Maximal Wall Thickness Measurement in Hypertrophic Cardiomyopathy: Biomarker Variability and its Impact on Clinical Care[J]. JACC Cardiovasc Imaging, 2021, 14(11): 2123-2134. doi: 10.1016/j.jcmg.2021.03.032
[22] Carvalho FP, Erthal F, Azevedo CF. The Role of Cardiac MR Imaging in the Assessment of Patients with Cardiac Amyloidosis[J]. Magn Reson Imaging Clin N Am, 2019, 27(3): 453-463. doi: 10.1016/j.mric.2019.04.005
[23] Saeed M, Van TA, Krug R, et al. Cardiac MR imaging: current status and future direction[J]. Cardiovasc Diagn Ther, 2015, 5(4): 290-310.
[24] Liguori C, Farina D, Vaccher F, et al. Myocarditis: imaging up to date[J]. Radiol Med, 2020, 125(11): 1124-1134. doi: 10.1007/s11547-020-01279-8
[25] Ojha V, Khurana R, Ganga KP, et al. Advanced cardiac magnetic resonance imaging in takotsubo cardiomyopathy[J]. Br J Radiol, 2020, 93(1115): 20200514. doi: 10.1259/bjr.20200514
[26] Rochitte CE, Liberato G, Silva MC. Comprehensive Assessment of Cardiac Involvement in Muscular Dystrophies by Cardiac MR Imaging[J]. Magn Reson Imaging Clin N Am, 2019, 27(3): 521-531. doi: 10.1016/j.mric.2019.04.009
[27] Kalisz K, Rajiah P. Impact of cardiac magnetic resonance imaging in non-ischemic cardiomyopathies[J]. World J Cardiol, 2016, 8(2): 132-145. doi: 10.4330/wjc.v8.i2.132
[28] Tadic M, Cuspidi C, Saeed S, et al. The role of cardiac magnetic resonance in diagnosis of cardiac sarcoidosis[J]. Heart Fail Rev, 2021, 26(3): 653-660. doi: 10.1007/s10741-020-10035-z
[29] Corrado D, Zorzi A, Cipriani A, et al. Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy[J]. J Am Heart Assoc, 2021, 10(18): e021987. doi: 10.1161/JAHA.121.021987
[30] Castrichini M, Eldemire R, Groves DW, et al. Clinical and genetic features of arrhythmogenic cardiomyopathy: diagnosis, management and the heart failure perspective[J]. Prog Pediatr Cardiol, 2021, 63: 101459. doi: 10.1016/j.ppedcard.2021.101459
[31] Chun KH, Oh J, Hong YJ, et al. Prognostic Cardiac Magnetic Resonance Markers of Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy for Predicting Heart Failure Outcomes[J]. J Am Heart Assoc, 2022, 11(6): e023167. doi: 10.1161/JAHA.121.023167
[32] Petersen SE, Selvanayagam JB, Wiesmann F, et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging[J]. J Am Coll Cardiol, 2005, 46(1): 101-105. doi: 10.1016/j.jacc.2005.03.045
[33] Gunda S, Ghannam M, Liang JJ, et al. The value of cardiac magnetic resonance imaging and programmed ventricular stimulation in patients with ventricular noncompaction and ventricular arrhythmias[J]. J Cardiovasc Electrophysiol, 2021, 32(3): 745-754. doi: 10.1111/jce.14884
[34] Szücs A, Kiss AR, Gregor Z, et al. Changes in strain parameters at different deterioration levels of left ventricular function: A cardiac magnetic resonance feature-tracking study of patients with left ventricular noncompaction[J]. Int J Cardiol, 2021, 331: 124-130. doi: 10.1016/j.ijcard.2021.01.072
[35] Dreisbach JG, Mathur S, Houbois CP, et al. Cardiovascular magnetic resonance based diagnosis of left ventricular non-compaction cardiomyopathy: impact of cine bSSFP strain analysis[J]. J Cardiovasc Magn Reson, 2020, 22(1): 9. doi: 10.1186/s12968-020-0599-3
[36] Perry R, Shah R, Saiedi M, et al. The Role of Cardiac Imaging in the Diagnosis and Management of Anderson-Fabry Disease[J]. JACC Cardiovasc Imaging, 2019, 12(7 Pt 1): 1230-1242.
[37] Militaru S, Ginghina C, Popescu BA, et al. Multimodality imaging in Fabry cardiomyopathy: from early diagnosis to therapeutic targets[J]. Eur Heart J Cardiovasc Imaging, 2018, 19(12): 1313-1322.
[38] Augusto JB, Johner N, Shah D, et al. The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage[J]. Eur Heart J Cardiovasc Imaging, 2021, 22(7): 790-799. doi: 10.1093/ehjci/jeaa101
[39] Meloni A, Maggio A, Positano V, et al. CMR for myocardial iron overload quantification: calibration curve from the MIOT Network[J]. Eur Radiol, 2020, 30(6): 3217-3225. doi: 10.1007/s00330-020-06668-1
[40] Tahir E, Fischer R, Grosse R, et al. Strain Analysis Using Feature-Tracking CMR to Detect LV Systolic Dysfunction in Myocardial Iron Overload Disease[J]. JACC Cardiovasc Imaging, 2020, 13(10): 2267-2268. doi: 10.1016/j.jcmg.2020.05.026
[41] Miura S, Naya M, Yamashita T. Iron Deficiency Anemia-Induced Cardiomyopathy With Congestive Heart Failure: Reversible Cardiac Dysfunction Assessed by Multi-Imaging Modalities[J]. JACC Case Rep, 2020, 2(11): 1806-1811. doi: 10.1016/j.jaccas.2020.07.051
[42] Nagao M, Matsuo Y, Kamitani T, et al. Quantification of myocardial iron deficiency in nonischemic heart failure by cardiac T2* magnetic resonance imaging[J]. Am J Cardiol, 2014, 113(6): 1024-1030. doi: 10.1016/j.amjcard.2013.11.061
[43] Yang Z, Wang H, Chang S, et al. Left ventricular strain-curve morphology to distinguish between constrictive pericarditis and restrictive cardiomyopathy[J]. ESC Heart Fail, 2021, 8(6): 4863-4872. doi: 10.1002/ehf2.13679
[44] Chetrit M, Natalie Szpakowski N, Desai MY. Multimodality imaging for the diagnosis and treatment of constrictive pericarditis[J]. Expert Rev Cardiovasc Ther, 2019, 17(9): 663-672. doi: 10.1080/14779072.2019.1657832
计量
- 文章访问数: 1893
- PDF下载数: 901
- 施引文献: 0